Business ❯ Mergers and Acquisitions ❯ Corporate Strategy

Investment

Technology Sector Biotech Investments Private Equity Market Competition Pharmaceutical Industry Valuation Digital Infrastructure Stock Transactions Modella Capital Stakeholder Engagement Private Companies Potential Buyers Biotech Companies Capital Markets Market Trends Global Expansion Fusion Energy Media Companies Robotics Venture Capital Regulatory Compliance Global Corporations

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

The move backs a design that strips IgE from immune cells to shut down allergic signaling faster.

AeroVironment Buys ESAero in $200 Million Deal to Accelerate Prototype-to-Production

Naver Financial to Acquire Upbit Owner Dunamu in $10.3 Billion Stock Swap

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform